Monthly Archives: May 2010
Almotriptan
MEDICATION SAFETY ISSUESSound-alike/look-alike issues: Axert® may be confused with Antivert® U.S. BRAND NAMES — Axert® PHARMACOLOGIC CATEGORYAntimigraine AgentSerotonin 5-HT1B, 1D Receptor Agonist DOSING: ADULTS — Migraine: Oral: Initial: 6.25-12.5 mg in a single dose; if the headache returns, repeat the … Continue reading
Tagged Acute Treatment, Adverse Reactions, Almotriptan, Antivert, Axert, Cardiac Evaluation, Central Nervous System, Cyp3a4, Daily Dose, Enzyme Inhibitor, Malate, Medication Safety, Mg Dosage, Mg Patients, Migraine, Receptor Agonist, Renal Impairment, Safety Issues, Somnolence, Vomiting
Comments Off